NeuroBytes: Medical Student Series:
Approach to A Patient With Chronic Headache
Course Description
Chronic headache disorders are a common problem globally and can cause significant disability. It is imperative that clinicians identify key features to distinguish primary vs secondary headache disorders, and initiate appropriate work-up for underlying secondary etiologies when warranted. The International Headache Society has created evidence-based headache criteria for headache disorders that can be easily reviewed using the
International Classification of Headache Disorders (ICHD-3). Most chronic headache disorders are treated with a combination of preventative treatments, rescue treatments, and lifestyle modification. In this video we review the key features of the most common primary and secondary chronic headache syndromes and treatment categories.
Learning Objectives
As a result of this program the learner will be able to:
- Apply a diagnostic framework to a patient with chronic headaches and identify common primary chronic headache disorders.
Date of Release
September 20, 2023
Confidentiality of Data
All material © American Academy of Neurology Institute unless otherwise indicated. All rights reserved. See complete
Terms of Use.
Faculty & Disclosures
DENNIS DELASI NYANYO
Medical Student
Harvard Medical School
Boston, MA
*Mr. Nyanyo has nothing to disclose.
SUMITA M. STRANDER
Medical Student
Harvard Medical School
Boston, MA
*Ms. Strander has nothing to disclose.
Editor
Reviewer
NeuroBytes Staff
Medical Student
Harvard Medical School
Boston, MA
*Mr. Nyanyo has nothing to disclose.
SUMITA M. STRANDER
Medical Student
Harvard Medical School
Boston, MA
*Ms. Strander has nothing to disclose.
Editor
ALEXANDRA HOVAGUIMIAN, MD
Assistant Professor of Neurology
Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center, Harvard Medical School
Boston, MA
*Dr. Hovaguimian has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Aquifer.
Reviewer
NURI JACOBY, MD
Assistant Professor of Neurology
SUNY Downstate College of Medicine
Attending Neurologist, Maimonides Medical Center
Brooklyn, NY
*Dr. Jacoby has no relevant disclosures to the production of this work. He has received the Faculty Innovation in Education Award from the American Board of Psychiatry and Neurology. He has served on an advisory board for Alexion pharmaceuticals.
HARINI SARVA, MD
Attending
Weill Cornell Medical Center
New York, NY
*Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Sarva has received personal compensation in the range of $0-$499 for serving as a Consultant for Cala Trio. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics.
AIMEE SZEWKA, MD, FAAN
Assistant Professor
Rush University Medical Center
Chicago, IL
*Dr. Szewka has nothing to disclose.
NeuroBytes Staff
Lucy Persaud, Associate Director, Graduate Education
Minneapolis, MN
*Ms. Persaud has nothing to disclose.
Xiaoyu Sun, Associate Director, eLearning
Minneapolis, MN
*Ms. Sun has nothing to disclose.
Robert Rook, Manager, eLearning
Minneapolis, MN
*Mr. Rook has nothing to disclose.
Michaela Morris, eLearning Program Manager
Minneapolis, MN
*Ms. Morris has nothing to disclose.
Sulia Altenberg, eLearning Coordinator
Minneapolis, MN
*Ms. Altenberg has nothing to disclose.
*Relationship Disclosure